| Literature DB >> 34822474 |
Araceli E Rossignoli1, Carmen Mariño1, Helena Martín1, Juan Blanco1.
Abstract
Prevalence and incidence of the marine toxins (paralytic, amnesic, and lipophilic toxins) including the so-called emerging toxins (these are, gymnodimines, pinnatoxins, or spirolides among others) have increased in recent years all over the world. Climate change, which is affecting the distribution of their producing phytoplankton species, is probably one of the main causes. Early detection of the toxins present in a particular area, and linking the toxins to their causative phytoplankton species are key tools to minimize the risk they pose for human consumers. The development of both types of studies requires fast and highly sensitive analytical methods. In the present work, we have developed a highly sensitive liquid chromatography-mass spectrometry methodology (LC-MS/MS), using a column with fused-core particle technology, for the determination of fourteen lipophilic toxins in a single run of 3.6 min. The performance of the method was evaluated for specificity, linearity, precision (repeatability and reproducibility) and accuracy by analysing spiked and naturally contaminated samples. The in-house validation was successful, and the limit of detection (LOD) and quantification (LOQ) for all the toxins were far below their regulatory action limits. The method is suitable to be considered in monitoring systems of bivalves for food control.Entities:
Keywords: LC-MS/MS; emerging toxins; fast method; lipophilic toxin; performance; screening
Mesh:
Substances:
Year: 2021 PMID: 34822474 PMCID: PMC8622501 DOI: 10.3390/md19110603
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structure of the main lipophilic toxins. Source: Leyva-Valencia et al. [15].
Figure 2Chromatogram with two MRM transitions (quantifier and qualifier) obtained from a mixture of reference solutions. Abbreviations: OA (okadaic acid), 45-OH YTX (45 hydroxyyessotoxin), DTX2 (dinophysistoxin 2), HomoYTX (Homoyessotoxin), YTX (yessotoxin), DTX1 (dinophysistoxin 1), AZA3 (azaspiracid 3), AZA1 (azaspiracid 1), AZA2 (azaspiracid 2), GYMA (gymnodimine A), 13,19diDesMetSPXC (13,19 didesmethylspirolide C), 13desmSPXC (13 desmethylspirolide C), PTX2 (pectenotoxin 2), 20MeSPXG (20 methylspirolide G), PnTXG (pinnatoxin G) (A); Zoom of second MRM transitions (qualifier) for OA, DTX2 and AZAs toxins (B).
Limits of detection (LOD) and quantitation (LOQ) obtained for fourteen lipophilic toxins.
| Toxin | LOD (µg kg−1) | LOQ (µg kg−1) |
|---|---|---|
| OA | 3 | 10 |
| DTX2 | 9 | 29 |
| DTX1 | 9 | 29 |
| AZA1 | 9 | 29 |
| AZA2 | 9 | 29 |
| AZA3 | 9 | 29 |
| YTX | 22 | 72 |
| HomoYTX | 24 | 74 |
| PTX2 | 7.3 | 25 |
| 13desmSPXC | 0.2 | 0.67 |
| 13,19didesmSPXC | 0.035 | 0.12 |
| 20MethylSPXG | 1.1 | 3.8 |
| GYMA | 1.2 | 3.9 |
| PnTXG | 0.4 | 1.3 |
Recovery values in fortified samples at levels around LOQ and performed under repeatability conditions.
| OA | DTX2 | DTX1 | AZA1 | AZA2 | AZA3 | PTX2 | YTX | HomoYTX | 13desmSPXC | 13,19didesmSPXC | 20MethySPXG | GYMA | PnTXG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fortified levels (µg kg−1) | ||||||||||||||
| 30 * | 30 | 30 | 30 | 30 | 30 | 30 | 75 | 75 | 0.7 | 3 * | 3 ** | 3 ** | 3 * | |
| Matrix | Recovery (%) | |||||||||||||
| Mussel | 89.3 | 100.3 | 114.7 | 89.7 | 82.3 | 87.3 | 94.3 | 135.5 | 119.2 | 100 | 84.3 | 105.7 | 103.3 | 56.9 |
| Clam | 71 | 80.7 | 96.7 | 75.7 | 91.7 | 79.3 | 81.3 | 96.7 | 92 | 85.7 | 79.7 | 99.3 | 101.7 | 78.6 |
| Oyster | 94 | 105.7 | 122 | 103 | 99.7 | 95 | 100.3 | 137.2 | 111.1 | 142.9 a | 75.7 | 91.7 | 42.4 a | 57.7 |
| Mean ( | 84.8 | 95.6 | 111.1 | 89.5 | 91.2 | 87.2 | 92.0 | 123.1 | 107.4 | 92.9 ( | 79.9 | 98.9 | 102.5 ( | 64.4 |
| SD ( | 12.2 | 13.2 | 13.0 | 13.7 | 8.7 | 7.9 | 9.7 | 22.9 | 14.0 | 10.1 ( | 4.30 | 7.0 | 1.1 ( | 12.3 |
| RSDr, % | 14.3 | 13.8 | 11.7 | 15.3 | 9.6 | 9 | 10.6 | 18.6 | 13.0 | 10.9 | 5.4 | 7.1 | 1.1 | 19.1 |
* Level of fortified slightly above its LOQ for simplicity of analysis. ** Level of fortified slightly below its LOQ for simplicity of analysis. a Data not considered for mean, SD and RSDr calculations.
Coefficient of determination (r2) obtained for the fourteen lipophilic toxins.
| Toxin | r2 |
|---|---|
| OA | 0.9922 |
| DTX2 | 0.9917 |
| DTX1 | 0.9918 |
| AZA1 | 0.9972 |
| AZA2 | 0.9972 |
| AZA3 | 0.9966 |
| YTX | 0.9891 |
| HomoYTX | 0.9922 |
| PTX2 | 0.9969 |
| 13desmSPXC | 0.9969 |
| 13,19didesmSPXC | 0.9921 |
| 20MethylSPXG | 0.9965 |
| GYMA | 0.9970 |
| PnTXG | 0.9958 |
Average RSDr (repeatability) and RSDR (reproducibility) of the studied toxin in the three evaluated matrices.
| Level 1 | Level 2 | Level 3 | Level 4 | Level 5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| RSDr, % | RSDR, % | RSDr, % | RSDR, % | RSDr, %( | RSDR, % | RSDr, % | RSDR, % | RSDr, % | RSDR, % | |
| OA | 8.6 | 6.5 | 4.4 | 7.9 | 4.8 | 5.8 | 3.6 | 5.0 | ||
| DTX2 | 8.5 | 7.9 | 4.3 | 6.4 | 4.7 | 6.7 | 5.7 | 6.7 | ||
| DTX1 | 10.1 | 10.0 | 6.6 | 9.6 | 5.6 | 9.7 | 3.8 | 8.9 | ||
| AZA1 | 11.3 | 10.7 | 3.1 | 4.1 | 3.7 | 3.2 | 3.6 | 3.4 | ||
| AZA2 | 8.1 | 7.7 | 4.7 | 4.9 | 3.7 | 3.0 | 4.1 | 3.2 | ||
| AZA3 | 9.3 | 8.5 | 4.5 | 4.8 | 3.0 | 2.7 | 4.0 | 3.2 | ||
| YTX | 16.0 | 14.4 | 14.9 | 14.2 | 14.0 | 13.7 | 12.5 | 13.9 | ||
| HomoYTX | 13.0 | 11.1 | 14.0 | 13.6 | 12.8 | 12.7 | 12.9 | 13.9 | ||
| PTX2 | 8.1 | 8.5 | 9.3 | 7.2 | 7.5 | 5.1 | 5.8 | 5.0 | ||
| 13desmSPXC | 21.2 ( | 30.6 ( | 18.3 | 17.4 | 6.4 | 7.4 | 6.9 | 6.7 | 8.9 | 8.9 |
| 13,19didesmSPXC | 15.2 | 14.8 | 4.9 | 10.2 | 5.4 | 6.4 | 7.6 | 8.3 | ||
| 20MethylSPXG | 17.8 ** | 16.5 ** | 4.1 | 4.8 | 4.7 | 6.0 | 6.1 | 7.5 | ||
| GYMA | 36.0 ** | 30.9 ** | 7.4 | 7.2 | 5.9 | 5.4 | 7.0 | 7.3 | ||
| PnTXG | 21.9 | 14.8 | 4.9 | 5.1 | 6.3 | 7.0 | 7.5 | 8.7 | ||
* Data from oyster were not considered for RSD calculations. ** Level of fortified slightly below its LOQ for simplicity of analysis.
Precision results for the analysis of naturally contaminated samples.
| Sample | Matrix | Toxin | RSDr % ( | RSDR % ( |
|---|---|---|---|---|
| 508 | Mussel | Total OA | 10.1 | 11.7 |
| 509 | Mussel | Total OA | 8.6 | 14.5 |
| 510 | Mussel | Total OA | 7.9 | 13.0 |
| 512 | Mussel | Total OA | 9.7 | 10.3 |
| 513 | Mussel | Total OA | 8.9 | 12.5 |
| 1532 | Cockle | Total OA | 9.6 | 12.6 * |
| 1534 | Cockle | Total OA | 8.7 | 8.1 * |
| 1540 | Razor clam | Total OA | 11.2 | 10.0 * |
| 1541 | Cockle | Total OA | 11.3 | 8.7 * |
| 1547 | Clam | Total OA | 8.0 | 6.9 * |
* n = 12
Recovery and reproducibility for CRM-FDMT material.
| Type of Toxin | Mean (µg kg−1) | SD (µg kg−1) | RSDR, % ( | Certified Value | Recovery % |
|---|---|---|---|---|---|
| OA | 306.7 | 22.8 | 7.4 | 278.3 | 110.2 |
| DTX2 | 795.1 | 64.6 | 8.1 | 624.8 | 129.1 |
| DTX1 | 155.7 | 11.6 | 7.5 | 119.0 | 132.0 |
| AZA1 | 809.1 | 70.5 | 8.7 | 717.5 | 112.3 |
| AZA2 | 194.3 | 12.9 | 6.6 | 197.8 | 98.1 |
| AZA3 | 186.9 | 12.5 | 6.7 | 168 | 110.6 |
| YTX | 670.0 | 176.5 | 26.3 | 435.8 | 154.1 |
| PTX2 | 107.6 | 12.7 | 11.8 | 115.5 | 92.4 |
| 13desmSPXC | 509.0 | 35.4 | 6.9 | 472.5 | 108.0 |
Toxin recoveries for different fortification levels in the three matrices studied under reproducibility conditions.
| Recovery, % (Mean ± SD), | |||||
|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Level 4 | Level 5 | |
| OA | 84.8 ± 1.6 | 85.6 ± 5.4 | 91.7 ± 8.5 | 93.8 ± 14.9 | |
| DTX2 | 90.4 ± 2.1 | 92.5 ± 4.7 | 99.6 ± 10.6 | 101.0 ± 21.6 | |
| DTX1 | 100.7 ± 3.0 | 105.7 ± 8.2 | 110.7 ± 17.2 | 112.9 ± 32.3 | |
| AZA1 | 89.9 ± 2.9 | 91.2 ± 3.0 | 96.0 ± 4.9 | 98.7 ± 10.7 | |
| AZA2 | 90.8 ± 2.1 | 91.8 ± 3.4 | 97.0 ± 4.6 | 99.3 ± 10.0 | |
| AZA3 | 88.2 ± 2.3 | 91.0 ± 3.5 | 97.4 ± 4.20 | 99.8 ± 10.3 | |
| YTX | 107.9 ± 11.6 | 113.0 ± 32.2 | 121.1 ± 66.6 | 120.5 ± 134.2 | |
| HomoYTX | 96.2 ± 8.0 | 100.7 ± 27.3 | 107.8 ± 54.7 | 107.4 ± 119.0 | |
| PTX2 | 85.7 ± 2.1 | 84.9 ± 4.9 | 89.1 ± 7.2 | 91. 5 ± 14.6 | |
| 13desmSPXC | 100.8 ± 0.2 ( | 71.1 ± 1.0 | 76.5 ± 1.3 | 83.4 ± 2.5 | 87.5 ± 6.9 |
| 13,19didesmSPXC | 72.8 ± 0.3 | 71.8 ± 2.2 | 67.1 ± 3.2 | 73.7 ± 9.2 | |
| 20MethylSPXG | 92.8 ** ± 0.5 | 98.9 ± 1.4 | 92.3 ± 4.1 | 101.7 ± 11.5 | |
| GYMA | 83.5 ** ± 0.8 | 97.2 ± 2.1 | 90.6 ± 3.7 | 99.3 ± 10.8 | |
| PnTXG | 62.0 ± 0.3 | 75.8 ± 1.2 | 70.3 ± 3.7 | 77.1 ± 10.0 | |
* Data from oyster have not been considered for recovery calculations. ** Level of fortified slightly below its LOQ for simplicity of analysis.
MS/MS fragmentation conditions for lipophilic toxin determination. ESI = electrospray ionization mode, Q1 = m/z ratio in the first quadrupole, Q3 = m/z ratio in the third quadrupole, DEP(v) = declustering potential, EP(v) = entrance potential, CE(v) = collision energy, and CXP(v) = collision cell exit potential, qn = ion pair for quantitation and ql = ion pair for qualifier purpose.
| Toxin | ESI | Q1 | Q3 | DEP (v) | EP (v) | CE (v) | CXP(v) |
|---|---|---|---|---|---|---|---|
| OA_DTX2 (qn) | NEG | 803.52 | 255.15 | −80 | −15 | −62 | −11 |
| OA_DTX2 (ql) | NEG | 803.52 | 563.40 | −80 | −15 | −60 | −11 |
| YTX (qn) | NEG | 570.43 | 467.40 | −80 | −15 | −42 | −11 |
| YTX (ql) | NEG | 570.43 | 396.40 | −80 | −15 | −42 | −11 |
| HomoYTX (qn) | NEG | 577.40 | 474.40 | −80 | −15 | −42 | −11 |
| HomoYTX (ql) | NEG | 577.40 | 403.40 | −80 | −15 | −42 | −11 |
| DTX1 (qn) | NEG | 817.50 | 255.15 | −80 | −15 | −60 | −11 |
| DTX1 (ql) | NEG | 817.50 | 563.45 | −80 | −15 | −52 | −11 |
| AZA3 (qn) | POS | 828.46 | 810.5 | 80 | 15 | 30 | 10 |
| AZA3 (ql) | POS | 828.46 | 658.4 | 80 | 15 | 43 | 10 |
| AZA1 (qn) | POS | 842.46 | 824.5 | 80 | 15 | 30 | 10 |
| AZA1 (ql) | POS | 842.46 | 672.4 | 80 | 15 | 43 | 10 |
| AZA2 (qn) | POS | 856.46 | 838.5 | 80 | 15 | 30 | 10 |
| AZA2 (ql) | POS | 856.46 | 672.4 | 80 | 15 | 43 | 10 |
| GYMA (qn) | POS | 508.33 | 490.2 | 80 | 15 | 50 | 10 |
| GYMA (ql) | POS | 508.33 | 136.00 | 80 | 15 | 50 | 10 |
| 13,19didesmSPXC (qn) | POS | 678.5 | 164.00 | 80 | 15 | 60 | 10 |
| 13,19didesmSPXC (ql) | POS | 678.50 | 430.3 | 80 | 15 | 50 | 10 |
| 13desmSPXC (qn) | POS | 692.5 | 164.3 | 80 | 15 | 60 | 10 |
| 13desmSPXC (ql) | POS | 692.50 | 444.3 | 80 | 15 | 55 | 10 |
| PTX2 (qn) | POS | 876.46 | 823.5 | 80 | 15 | 35 | 10 |
| PTX2 (ql) | POS | 876.46 | 213.1 | 80 | 15 | 50 | 10 |
| 20MethylSPXG (qn) | POS | 706.5 | 164.3 | 80 | 15 | 60 | 10 |
| 20MethylSPXG (ql) | POS | 706.50 | 348.3 | 80 | 15 | 55 | 10 |
| PnTXG (qn) | POS | 694.5 | 164.3 | 80 | 15 | 60 | 10 |
| PnTXG (ql) | POS | 694.5 | 440.3 | 80 | 15 | 50 | 10 |
Toxin concentrations in ng mL−1 used to evaluate the linearity of the method.
| OA, DTXs, AZAs, PTX2 | YTX, HomoYTX | 13desmSPXC | 13,19didesmSPXC, 20MethylSPXG, GYMA, PnTXG |
|---|---|---|---|
| 2.1 | 5.2 | 0.19 | 0.47 |
| 6.3 | 15.7 | 0.6 | 0.9 |
| 10.6 | 26.5 | 1.8 | 1.9 |
| 16.9 | 42.1 | 3.0 | 3.75 |
| 21.6 | 53.9 | 4.7 | 7.5 |
| 31.7 | 79.2 | 6 | 15 |
| 45.7 | 114.29 | 8.8 | |
| 12.7 |
Toxin concentrations in µg kg−1 used to fortify blank samples.
| Level 1 | Level 2 | Level 3 | Level 4 | Level 5 | |
|---|---|---|---|---|---|
| OA | 30 | 80 | 160 | 320 | |
| DTXs | 30 | 80 | 160 | 320 | |
| AZAs | 30 | 80 | 160 | 320 | |
| PTX2 | 30 | 80 | 160 | 320 | |
| YTX | 75 | 200 | 400 | 800 | |
| HomoYTX | 75 | 200 | 400 | 800 | |
| 13desmSPXC | 0.7 | 8.3 | 22.2 | 44.4 | 89 |
| GYMA | 3 | 30 | 75 | 150 | |
| PnTXG | 3 | 30 | 75 | 150 | |
| 13,19didesmSPXC | 3 | 30 | 75 | 150 | |
| 20MethylSPXG | 3 | 30 | 75 | 150 |